Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study

Blood (2022) 140 (Supplement 1): 3816–3817.

https://doi.org/10.1182/blood-2022-165149

Published: 2022

Journal Articles

COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic

Shlomzion Aumann, Uria Tsubary, Sarah Israel, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, Vladimir Vainstein, Diana Libster, Revital Saban, Adir Shaulov, Batia Avni, Boaz Nachmias, Sigal Grisariu, Ora Paltiel, Moshe Gatt, Eran Zimran

Blood (2021) 138 (Supplement 1): 4088.

https://doi.org/10.1182/blood-2021-148512

Published: 2021

Journal Articles

Post-Treatment FDG-Avid Splenic Lesions in DLBCL: Clinical and Radiographic Characteristics for Risk Assessment

Boaz Nachmias, MD PhD, Geremy Godefroy, MD, Chezi Ganzel, MD, Neta Goldschmidt, MD, Eyal Rozenbach, MD, Rachel Bar-Shalom, MD, Diana Libster, MD, Vladimir Vainstein, MD

Blood (2019) 134 (Supplement_1): 5358.

https://doi.org/10.1182/blood-2019-121473

Published: 2019

Journal Articles

Favorable Outcome of Primary Mediastinal Large B-Cell Lymphoma Patients Treated with Sequential R-CHOP/R- ICE Regimen Omitting Radiation

Neta Goldschmidt, MD, Ora B. Paltiel, MDM, MSc, Dina Ben Yehuda, Geffen Kleinstern, Alexander Gural, MD, Diana Libster, MD, David Lavie, MD, Moshe E. Gatt, MD

Blood (2015) 126 (23): 3954.

https://doi.org/10.1182/blood.V126.23.3954.3954

Published: 2015

Journal Articles

Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

Jacob Vine, medical student, Sara Bar Cohen, PhD, Rosa Ruchlemer, Neta Goldschmidt, MD, Moshe Levin, MD, Diana Libster, MD, Alexander Gural, MD, Moshe E. Gatt, MD, David Lavie, MD, Dina Ben-Yehuda, MD, Deborah Rund, MD

Blood (2012) 120 (21): 1340.

https://doi.org/10.1182/blood.V120.21.1340.1340

Published: 2012

Journal Articles

Polymorphisms in Exons 2 and 7 of the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients,

Jacob Vine, medical student, Sara Bar Cohen, PhD, Rosa Ruchlemer, MD, Neta Goldschmidt, MD, Moshe Levin, MD, Diana Libster, MD, Alexander Gural, MD, Moshe E. Gatt, MD, David Lavie, Dina Ben-Yehuda, MD, Deborah Rund, MD

Blood (2011) 118 (21): 3487.

https://doi.org/10.1182/blood.V118.21.3487.3487

Published: 2011

Journal Articles

Six Cycles of BEACOPP Tailored Based on Interim Scintigraphy Provide Favorable Outcome for Patients with Standard and Advanced Risk Hodgkin Lymphoma and Female Fertility Is Preserved: Results of a 10-Year Follow-up

Eldad J Dann, MD, Zeev Blumenfeld, MD, Rachel Bar-Shalom, MD, Irit Avivi, MD, Menachem Ben-Shachar, MD, Odelia Goor, MD, Diana Libster, MD, Diana Gaitini, MD, Jacob M. Rowe, MD, Ron Epelbaum, MD

Blood (2011) 118 (21): 1564.

https://doi.org/10.1182/blood.V118.21.1564.1564

Published: 2011

Journal Articles

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.

Eldad Dann, MD, Rachel Bar-Shalom, MD, Ada Tamir, PhD, Menachem Ben-Shachar, MD, Irit Avivi, MD, Tsila Zuckerman, MD, Nuhad Haddad, MD, Hanna Rosenbaum, MD, Riva Fineman, MD, Odelia Goor, MD, Diana Libster, MD, Zeev Blumenfeld, MD, Jacob M. Rowe, MD, Ron Epelbaum, MD

Blood (2009) 114 (22): 1552.

https://doi.org/10.1182/blood.V114.22.1552.1552

Published: 2009

Journal Articles

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

Eldad J. Dann, Rachel Bar-Shalom, Ada Tamir, Nissim Haim, Menachem Ben-Shachar, Irit Avivi, Tzila Zuckerman, Mark Kirschbaum, Odelia Goor, Diana Libster, Jacob M. Rowe, Ron Epelbaum

Blood (2006) 109 (3): 905–909.

https://doi.org/10.1182/blood-2006-04-019901

Published: 2006

Journal Articles

Risk Adapted BEACOPP Regimen Based on Early Scintigraphy Can Reduce the Cumulative Dose of Chemotherapy for Standard and High Risk Hodgkin Lymphoma (HD) with No Impairment of Outcome.

Eldad J. Dann, MD, Rachel Bar Shalom, MD, Nissim Haim, MD, Ada Tamir, Ph.D, Menachem Ben Shachar, MD, Irit Avivi, MD, Tsila Zuckerman, MD, Mark Kirschbaum, MD, Odelia Goor, MD, Diana Libster, MD, Jacob M. Rowe, MD, Ron Apelbaum, MD

Blood (2005) 106 (11): 815.

https://doi.org/10.1182/blood.V106.11.815.815

Published: 2005

Journal Articles

Surgical Complications in Patients Treated with Chemotherapy for Gastric Diffuse Large B Cell Lymphoma.

Galia Spectre, MD, Diana Libster, MD, Sigal Grisariu, MD, Nael Da’as, MD, Zvi Gimmon, MD, Ora Paltiel, MDCM

Blood (2005) 106 (11): 4732.

https://doi.org/10.1182/blood.V106.11.4732.4732

Published: 2005

NARROW

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study

COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic

Post-Treatment FDG-Avid Splenic Lesions in DLBCL: Clinical and Radiographic Characteristics for Risk Assessment

Favorable Outcome of Primary Mediastinal Large B-Cell Lymphoma Patients Treated with Sequential R-CHOP/R- ICE Regimen Omitting Radiation

Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

Polymorphisms in Exons 2 and 7 of the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients,

Six Cycles of BEACOPP Tailored Based on Interim Scintigraphy Provide Favorable Outcome for Patients with Standard and Advanced Risk Hodgkin Lymphoma and Female Fertility Is Preserved: Results of a 10-Year Follow-up

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

Risk Adapted BEACOPP Regimen Based on Early Scintigraphy Can Reduce the Cumulative Dose of Chemotherapy for Standard and High Risk Hodgkin Lymphoma (HD) with No Impairment of Outcome.

Surgical Complications in Patients Treated with Chemotherapy for Gastric Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only